The pandemic has accelerated a revolution in medtech, impacting how companies approach their business strategy as well as how healthcare systems interact with medical device companies.
A discussion of the changing medtech markets and how companies can remain cognizant of potentially disruptive changes in their business and industry for future success in their product portfolios, services and relationships.
Expect to see slow growth and more mergers & acquisitions.
According to recent analysis by PwC, deal volume declined from 13 deals in the third quarter of 2014 to 9 deals in the fourth quarter. However, deal value increased from $3.7 billion to $4.9 billion over the same period.